MD Anderson Brings Underdogs into the Fight Against Cancer with Cancer Focus Fund

With an initial capital of $50 million, MD Anderson and partner The Focus Fund hope to invest in small biotechs with big cancer-fighting potential.

Previous
Previous

Mereo and Focus Fund Announce Etigilimab partnership with MD Anderson

Next
Next

Cancer Focus Fund and MD Anderson Launch Investment Fund to Underwrite Promising Cancer Therapies in Clinical Trials